Health Canada is pleased to release Health Canada New Drug Authorizations: 2016 Highlights ... Ltd - Praxbind is used as an antidote specific for dabigatran in patients treated with Pradaxa ...

The prescribed dosage for Rezdiffra (resmetirom) may depend on a person’s individual treatment plan. Factors like your medical history and body weight may affect your dosage of Rezdiffra.

The prescribed dosage for Sandostatin (octreotide acetate) may depend on a person’s individual treatment plan. Factors such as your medical history may affect your dosage of Sandostatin.

Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

Telix Pharmaceuticals' said its new drug application in the U.S. for an imaging agent received regulatory approval. The Melbrourne, Australia-based biopharmaceutical company said Friday that the Food ...

All of this applies to the molecules in pills, too. "Since 1985, drug manufacturers had only been aware of one polymorphic form of rotigotine—a medication prescribed for the treatment of ...

A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug ...

The dosage for Abilify (aripiprazole) may depend on the condition being treated and the form of the drug prescribed. Other factors, including your age and how you respond to treatment, may affect ...

These structures can be used to accurately place things like biomolecules, cells, and nanoparticles in the context of drug delivery and other use cases. To create these structures, scientists ...

Adjusted-dosage warfarin 2.1 a p < 0.0001 for noninferiority to enoxaparin. b p = 0.017 for noninferiority to enoxaparin. c p = 0.0003 for noninferiority to enoxaparin. d Values failed to show ...

The contract, as previously announced, will see PharmAla develop a new 20mg clinical drug product dose of its LaNeo™ MDMA; This will allow significantly more variability in dosing for clinical ...